Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
(Pyrimidin-5-yl)boronic acid → N-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(pyrimidin-5-yl)benzamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | (Pyrimidin-5-yl)boronic acid | HCID 2795193 | — |
| 반응물 | N-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-iodobenzamide | HCID 89907118 | — |
| 생성물 | N-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(pyrimidin-5-yl)benzamide | HCID 89907137 | — |
반응 단계
The title compound was prepared in an analogous fashion to that described infashion to that described in Example 1 using N-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-iodobenzamide (Stage 9.1) and pyrimidin-5-ylboronic acid to afford the title compound as a white solid. UPLC-MS (Condition 1) tR=2.63 min, m/z=378.0 [M+H]+, m/z=376.1 [M−H]−; 1H-NMR (400 MHz, DMSO-d6) δ ppm 7.56-7.64 (m, 1H) 7.66 (dd, J=9.0, 1.2 Hz, 1H) 7.70-7.76 (m, 1H) 7.97-8.11 (m, 3H) 8.36 (s, 1H) 9.25 (s, 1H) 9.26 (s, 2H) 10.67 (s, 1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09315489B2 |
| 출처 데이터셋 | uspto-grants-2016_04 |
| ORD ID | ord-49dae3715d074633ad88a8500279d6f3 |
| 출처 메모 | uspto-grants-2016_04 |